
Losing Strategies
<p>As the head of the U.S. Department of Health and Human Services announced Monday that he was ordering a review of a planned 15% hike in the Medicare Part B premium for 2022, healthcare reform advocates stressed the need for Congress to pass a Build Back Better bill with a provision allowing the federal government to negotiate the price of prescription drugs. Corbevax is targeting low-income countries to stop new COVID variants from emerging. Scientists say rich countries are still refusing to fund it. Two absolutely insane op-ed pieces on the same day: Hillary Clinton 2024 Election Comeback and Biden-Cheney 2024. In an interview with OAN, Trump reiterates that he took the booster, and even takes shots on Ron DeSantis.</p><br><p>Hosts: Ana Kasparian</p><br /><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
Audio is streamed directly from the publisher (podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
As the head of the U.S. Department of Health and Human Services announced Monday that he was ordering a review of a planned 15% hike in the Medicare Part B premium for 2022, healthcare reform advocates stressed the need for Congress to pass a Build Back Better bill with a provision allowing the federal government to negotiate the price of prescription drugs. Corbevax is targeting low-income countries to stop new COVID variants from emerging. Scientists say rich countries are still refusing to fund it. Two absolutely insane op-ed pieces on the same day: Hillary Clinton 2024 Election Comeback and Biden-Cheney 2024. In an interview with OAN, Trump reiterates that he took the booster, and even takes shots on Ron DeSantis.
Hosts: Ana Kasparian
Hosted on Acast. See acast.com/privacy for more information.
Learn more about your ad choices. Visit podcastchoices.com/adchoices